Polling Questions


< All Questions
According to the webcast:

with Sharon J. Parish, MD , IF, NCMP
In their briefing document, Division Summary, phase 3 placebo-controlled trials, on flibanserin, depression, and SS/RIs, the FDA states:
 Combination of flibanserin with SS/NRI did not exacerbated dizziness and insomnia
 Flibanserin did not exacerbate depression or anxiety in patients taking SSRI or SNRI medication (in dedicated SSRI study)
 Flibanserin is contraindicated in patients on SSRI/SNRI medication
 Adverse events affected over 25% of participating patients
 
 

Your answers are confidential and will be used for educational purposes only.

Submit